FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948653004> ?p ?o ?g. }

• W2948653004 endingPage "11" @default.
• W2948653004 startingPage "1" @default.
• W2948653004 abstract "Peroxiredoxin II (Prx II), an antioxidant enzyme in the Prx family, reduces oxidative stress by decreasing the intracellular ROS levels. Osteoblast differentiation is promoted by bone morphogenetic protein 2 (BMP2), which upregulates the expression of osteoblast differentiation marker genes, through Smad1/5/9 phosphorylation. We found that Prx II expression was increased by a high dose of lipopolysaccharide (LPS) but was not increased by a low dose of LPS. Prx II itself caused a decrease in the osteogenic gene expression, alkaline phosphatase (ALP) activity, and Smad1/5/9 phosphorylation induced by BMP2. In addition, BMP2-induced osteogenic gene expression and ALP activity were higher in Prx II knockout (KO) cells than they were in wild-type (WT) cells. These inhibitory effects were mediated by protein phosphatase 2A Cα (PP2A Cα), which was increased and is known to induce the dephosphorylation of Smad1/5/9. The overexpression of Prx II increased the expression of PP2A Cα, and PP2A Cα was not expressed in Prx II KO cells. Moreover, PP2A Cα reduced the level of BMP2-induced osteogenic gene expression and Smad1/5/9 phosphorylation. LPS inhibited BMP2-induced Smad1/5/9 phosphorylation and the suppressed phosphorylation was restored by the PP2A inhibitor okadaic acid (OA). Bone phenotype analyses using microcomputed tomography (μCT) revealed that the Prx II KO mice had higher levels of bone mass than the levels of the WT mice. We hypothesize that Prx II has a negative role in osteoblast differentiation through the PP2A-dependent dephosphorylation of Smad1/5/9. An antioxidant enzyme actively works to reduce bone synthesis under oxidative stress conditions in order to protect bone cells from damage and cell death. Bone is generated by cells called osteoblasts, which differentiate from stem cells. In osteoporosis and diabetes, excessive reactive oxygen species (ROS) within cells can disrupt osteoblast differentiation. South Korean researchers led by Eun-jung Kim at Kyungpook National University, Daegu, and Won-Gu Jang at Daegu University, Gyeongbuk, have shown that an antioxidant enzyme, peroxiredoxin II (PrxII), helps regulate bone formation under oxidative stress. The team generated PrxII-deficient mice and compared them with healthy normal mice. Under oxidative stress conditions, the mice had higher bone mass and higher expression of genes related to bone formation than the normal mice. PrxII limits osteoblast differentiation during elevated ROS by influencing associated protein activity and signalling pathways." @default.
• W2948653004 created "2019-06-14" @default.
• W2948653004 creator A5020591672 @default.
• W2948653004 creator A5026281003 @default.
• W2948653004 creator A5053296598 @default.
• W2948653004 creator A5067683921 @default.
• W2948653004 creator A5087390934 @default.
• W2948653004 creator A5090333823 @default.
• W2948653004 creator A5091385586 @default.
• W2948653004 date "2019-06-01" @default.
• W2948653004 modified "2023-10-16" @default.
• W2948653004 title "Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation" @default.
• W2948653004 cites W1599253395 @default.
• W2948653004 cites W1791153000 @default.
• W2948653004 cites W1965362098 @default.
• W2948653004 cites W1967647163 @default.
• W2948653004 cites W1968755117 @default.
• W2948653004 cites W1968859181 @default.
• W2948653004 cites W1969670678 @default.
• W2948653004 cites W1972236331 @default.
• W2948653004 cites W1974656242 @default.
• W2948653004 cites W1985776151 @default.
• W2948653004 cites W1988188873 @default.
• W2948653004 cites W1988449390 @default.
• W2948653004 cites W1992415952 @default.
• W2948653004 cites W2000769293 @default.
• W2948653004 cites W2002030791 @default.
• W2948653004 cites W2002315967 @default.
• W2948653004 cites W2016091065 @default.
• W2948653004 cites W2017958579 @default.
• W2948653004 cites W2018139994 @default.
• W2948653004 cites W2021426176 @default.
• W2948653004 cites W2022239851 @default.
• W2948653004 cites W2022822304 @default.
• W2948653004 cites W2026225426 @default.
• W2948653004 cites W2032635496 @default.
• W2948653004 cites W2034614189 @default.
• W2948653004 cites W2038446543 @default.
• W2948653004 cites W2047654882 @default.
• W2948653004 cites W2051531582 @default.
• W2948653004 cites W2055028932 @default.
• W2948653004 cites W2055408325 @default.
• W2948653004 cites W2066365078 @default.
• W2948653004 cites W2067917034 @default.
• W2948653004 cites W2072261716 @default.
• W2948653004 cites W2082018404 @default.
• W2948653004 cites W2084457999 @default.
• W2948653004 cites W2084674877 @default.
• W2948653004 cites W2084776852 @default.
• W2948653004 cites W2085425025 @default.
• W2948653004 cites W2086594627 @default.
• W2948653004 cites W2102934052 @default.
• W2948653004 cites W2110149781 @default.
• W2948653004 cites W2118773733 @default.
• W2948653004 cites W2133468132 @default.
• W2948653004 cites W2139055053 @default.
• W2948653004 cites W2150381945 @default.
• W2948653004 cites W2158496331 @default.
• W2948653004 cites W2605983902 @default.
• W2948653004 cites W2771656720 @default.
• W2948653004 cites W4237593632 @default.
• W2948653004 doi "https://doi.org/10.1038/s12276-019-0263-x" @default.
• W2948653004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6546700" @default.
• W2948653004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31160554" @default.
• W2948653004 hasPublicationYear "2019" @default.
• W2948653004 type Work @default.
• W2948653004 sameAs 2948653004 @default.
• W2948653004 citedByCount "12" @default.
• W2948653004 countsByYear W29486530042020 @default.
• W2948653004 countsByYear W29486530042021 @default.
• W2948653004 countsByYear W29486530042022 @default.
• W2948653004 countsByYear W29486530042023 @default.
• W2948653004 crossrefType "journal-article" @default.
• W2948653004 hasAuthorship W2948653004A5020591672 @default.
• W2948653004 hasAuthorship W2948653004A5026281003 @default.
• W2948653004 hasAuthorship W2948653004A5053296598 @default.
• W2948653004 hasAuthorship W2948653004A5067683921 @default.
• W2948653004 hasAuthorship W2948653004A5087390934 @default.
• W2948653004 hasAuthorship W2948653004A5090333823 @default.
• W2948653004 hasAuthorship W2948653004A5091385586 @default.
• W2948653004 hasBestOaLocation W29486530041 @default.
• W2948653004 hasConcept C11960822 @default.
• W2948653004 hasConcept C153911025 @default.
• W2948653004 hasConcept C160160445 @default.
• W2948653004 hasConcept C178666793 @default.
• W2948653004 hasConcept C181199279 @default.
• W2948653004 hasConcept C181912034 @default.
• W2948653004 hasConcept C185592680 @default.
• W2948653004 hasConcept C202751555 @default.
• W2948653004 hasConcept C2778260815 @default.
• W2948653004 hasConcept C30352789 @default.
• W2948653004 hasConcept C389152 @default.
• W2948653004 hasConcept C55493867 @default.
• W2948653004 hasConcept C86803240 @default.
• W2948653004 hasConcept C95444343 @default.
• W2948653004 hasConceptScore W2948653004C11960822 @default.
• W2948653004 hasConceptScore W2948653004C153911025 @default.
• W2948653004 hasConceptScore W2948653004C160160445 @default.

• next